Recent advances in pyroptosis, liver disease, and traditional Chinese medicine: A review
Phytotherapy Research · 2023-12 · 37 (12) · 5473-5494
DOI: 10.1002/ptr.7989 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytotherapy Research, online erschienen am 25.08.2023. Verfasst von Wenxing He und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chinese Medicine Science, Guangxi University of Chinese Medicine, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Pyroptosis, Liver Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 167 Literaturangaben. Gefördert von: Guangxi Natural Science Foundation, Guangxi Young and Middle-aged Teachers & Research Ability Improvement Project, Innovation Research Team Project of Guangxi Natural Science Foundation.
Abstract (Originalsprache)
In recent years, the incidence of liver disease has increased, becoming a major cause of death. Various liver diseases are intricately linked to pyroptosis, which is one of the most common forms of programmed cell death. As a powerful weapon in the fight against liver diseases, traditional Chinese medicine (TCM) can affect pyroptosis via a number of routes, including the classical, nucleotide oligomerization domain‐like receptors protein 3/caspase‐1/gasdermin D (GSDMD) pathway, the nonclassical lipopolysaccharide/caspase‐11/GSDMD pathway, the ROS/caspase‐3/gasdermin E pathway, the caspase‐9/caspase‐3/GSDMD pathway, and the Apaf‐1/caspase‐11/caspase‐3 pathway. In this review, we provide an overview of pyroptosis, the interplay between pyroptosis and liver diseases, and the mechanisms through which TCM regulates pyroptosis in liver diseases. The information used in the text was collected and compiled from the databases of PubMed, Web of Science, Scopus, CNKI, and Wanfang Data up to June 2023. The search was not limited with regard to the language and country of the articles. Research and review articles were included, and papers with duplicate results or unrelated content were excluded. We examined the current understanding of the relationship between pyroptosis and liver diseases as well as the advances in TCM interventions to provide a resource for the identification of potential targets for TCM in the treatment of liver diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Chinese Medicine Science, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
- Department of Hepatology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
- Department of Acupuncture-Moxibustion and Tuina, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China.
- The First Clinical Medical College, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
ORCID-Profile: Wenxing He, Canli Xu
Förderung
- Guangxi Natural Science Foundation
- Guangxi Young and Middle-aged Teachers & Research Ability Improvement Project
- Innovation Research Team Project of Guangxi Natural Science Foundation
- National Natural Science Foundation of China
- Natural Science Foundation of Guangxi Zhuang Autonomous Region
Zitieren
APA
He, W., Xu, C., Mao, D., Zheng, Y., Wang, N., Wang, M., Mao, N., Wang, T., & Li, Y. (2023). Recent advances in pyroptosis, liver disease, and traditional Chinese medicine: A review. Phytotherapy Research, 37(12), 5473-5494. https://doi.org/10.1002/ptr.7989
Vancouver
He W, Xu C, Mao D, Zheng Y, Wang N, Wang M, et al. Recent advances in pyroptosis, liver disease, and traditional Chinese medicine: A review. Phytotherapy Research. 2023;37(12):5473-5494. doi:10.1002/ptr.7989
BibTeX
@article{He2023,
author = {He, Wenxing and Xu, Canli and Mao, Dewen and Zheng, Yang and Wang, Na and Wang, Minggang and Mao, Nan and Wang, Ting and Li, Yanjie},
title = {Recent advances in pyroptosis, liver disease, and traditional Chinese medicine: A review},
journal = {Phytotherapy Research},
year = {2023},
volume = {37},
number = {12},
pages = {5473--5494},
doi = {10.1002/ptr.7989}
}
EUVIMED